Acimtamig, CAS 2738880-26-5

Product Description: Acimtamig (AFM13) is a CD30/CD16A bispecific innate cell engager. Acimtamig binds to the CD16A expressed on natural killer (NK) cells and binds to CD30 on CD30-expressing tumor cells, thereby selectively cross-linking tumor and NK cells. Acimtamig can be used for the study of eripheral T-cell lymphoma (PTCL)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Acimtamig/[2]Kim WS, et al. A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas. Clin Cancer Res. 2025 Jan 6;31(1):65-73.

CAS Number: 2738880-26-5

Molecular Weight: N/A

Research Area: Cancer

Target: TNF Receptor

• Artikelnummer: MEXHY-P990710-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P990710-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated